MeSH term
Frequency | Condition_Probility | Animals | 15 | 0.0 |
Genetic Vectors | 2 | 0.0 |
Hamsters | 2 | 0.0 |
Hela Cells | 3 | 0.0 |
Humans | 48 | 0.0 |
RNA, Messenger/metabolism | 2 | 0.0 |
Research Support, Non-U.S. Gov't | 33 | 0.0 |
*Transcription, Genetic | 2 | 0.0 |
Transfection | 2 | 0.0 |
5-Aminolevulinate Synthetase/*genetics | 23 | 88.0 |
Adult | 11 | 0.0 |
Anemia, Sideroblastic/*genetics | 13 | 68.0 |
Codon, Nonsense | 3 | 2.0 |
Male | 27 | 0.0 |
Mutation, Missense | 3 | 0.0 |
Aged | 6 | 0.0 |
Aged, 80 and over | 4 | 0.0 |
Codon | 2 | 0.0 |
Female | 24 | 0.0 |
Family Health | 7 | 0.0 |
Base Sequence | 15 | 0.0 |
DNA Mutational Analysis | 3 | 0.0 |
Linkage (Genetics) | 10 | 0.0 |
Middle Aged | 6 | 0.0 |
Mutation | 7 | 0.0 |
X Chromosome/*genetics | 8 | 2.0 |
Adolescent | 5 | 0.0 |
Alleles | 2 | 0.0 |
Blood Transfusion | 2 | 1.0 |
Heterozygote | 3 | 0.0 |
Pedigree | 13 | 0.0 |
Pyridoxine/therapeutic use | 4 | 28.0 |
Research Support, U.S. Gov't, P.H.S. | 23 | 0.0 |
Conserved Sequence | 2 | 0.0 |
Erythrocytes/*enzymology | 8 | 1.0 |
Mice | 5 | 0.0 |
Molecular Sequence Data | 16 | 0.0 |
Mutagenesis, Site-Directed | 3 | 0.0 |
Regulatory Sequences, Nucleic Acid | 2 | 0.0 |
Sequence Analysis, DNA | 2 | 0.0 |
Transcription, Genetic | 2 | 0.0 |
Tumor Cells, Cultured | 2 | 0.0 |
Chromosome Mapping | 10 | 0.0 |
Genetic Markers | 4 | 0.0 |
Hybrid Cells | 3 | 0.0 |
Microsatellite Repeats | 4 | 0.0 |
*X Chromosome | 15 | 1.0 |
*Gene Expression Regulation, Enzymologic | 2 | 0.0 |
Introns | 2 | 0.0 |
Iron/metabolism | 2 | 1.0 |
Transcription Factors/metabolism | 4 | 0.0 |
5-Aminolevulinate Synthetase/blood/*genetics | 2 | 100.0 |
Exons | 3 | 0.0 |
*Mutation, Missense | 2 | 0.0 |
Polymerase Chain Reaction | 7 | 0.0 |
Pyridoxine/*therapeutic use | 2 | 20.0 |
Comparative Study | 3 | 0.0 |
Centromere/genetics | 2 | 2.0 |
Lod Score | 4 | 0.0 |
Mental Retardation/*genetics | 3 | 1.0 |
Polymorphism, Restriction Fragment Length | 2 | 0.0 |
Syndrome | 2 | 0.0 |
Child | 3 | 0.0 |
DNA Primers | 2 | 0.0 |
*Mutation | 5 | 0.0 |
Haplotypes | 2 | 0.0 |
Models, Genetic | 3 | 0.0 |
Polymorphism, Genetic | 3 | 0.0 |
Recombination, Genetic | 3 | 0.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 3 | 0.0 |
Anemia, Sideroblastic/drug therapy/enzymology/*genetics | 3 | 100.0 |
Amino Acid Sequence | 6 | 0.0 |
Cloning, Molecular | 2 | 0.0 |
Phenotype | 3 | 0.0 |
Sequence Homology, Amino Acid | 3 | 0.0 |
Arginine/genetics | 2 | 1.0 |
Point Mutation | 4 | 0.0 |
5-Aminolevulinate Synthetase/*genetics/metabolism | 2 | 100.0 |
Genes, Reporter | 3 | 0.0 |
Promoter Regions (Genetics) | 2 | 0.0 |
5-Aminolevulinate Synthetase/genetics | 3 | 60.0 |
Isoenzymes/genetics | 2 | 0.0 |
*Linkage (Genetics) | 4 | 0.0 |
Heme/biosynthesis | 2 | 11.0 |
Binding Sites | 2 | 0.0 |
Centromere | 2 | 2.0 |
In Situ Hybridization | 2 | 0.0 |
Mice, Inbred C57BL | 2 | 0.0 |
Karyotyping | 2 | 0.0 |
Oligonucleotide Probes | 2 | 0.0 |
5-Aminolevulinate Synthetase/biosynthesis/*genetics | 2 | 100.0 |
*Point Mutation | 2 | 0.0 |
Recombinant Fusion Proteins/biosynthesis | 2 | 0.0 |
Mitochondria/metabolism | 2 | 0.0 |
RNA, Messenger/biosynthesis | 2 | 0.0 |
